Racial differences in clinical treatment and self-care behaviors of adults with chronic heart failure

Victoria Vaughan Dickson, George J. Knafl, Joyce Wald, Barbara Riegel

Research output: Contribution to journalArticle

Abstract

Background-In the United States, the highest prevalence of heart failure (HF) is in blacks followed by whites. Compared with whites, blacks have a higher risk of HF-related morbidity and mortality and HF-related hospitalization. Little research has focused on explaining the reasons for these disparities. The purpose of this study was to examine racial differences in demographic and clinical characteristics in blacks and whites with HF and to determine if these characteristics influenced treatment, or together with treatment, influenced self-care behaviors. Methods and Results-This was a secondary analysis of existing data collected from adults (n=272) with chronic HF enrolled from outpatient sites in the northeastern United States and followed for 6 months. After adjusting for sociodemographic and clinical characteristics within reduced (HFrEF) and preserved ejection fraction (HFpEF) groups, there were 2 significant racial differences in clinical treatment. Blacks with HFrEF were prescribed ACE inhibitors and hydralazine and isosorbide dinitrate (H-ISDN) more often than whites. In the HFpEF group, blacks were taking more medications and were prescribed digoxin and a diuretic when symptomatic. Deficits in HF knowledge and decreased medication adherence, objectively measured, were more prominent in blacks. These racial differences were not explained by sociodemographic or clinical characteristics or clinical treatment variables. Premorbid intellect and the quality of support received contributed to clinical treatment and self-care. Conclusion-Although few differences in clinical treatment could be attributed solely to race, knowledge about HF and medication adherence is lower in blacks than whites. Further research is needed to explain these observations, which may be targets for future intervention research.

Original languageEnglish (US)
Article numbere001561
JournalJournal of the American Heart Association
Volume4
Issue number4
DOIs
StatePublished - 2015

Fingerprint

Self Care
Heart Failure
Medication Adherence
Therapeutics
Research
Isosorbide Dinitrate
Hydralazine
New England
Digoxin
Angiotensin-Converting Enzyme Inhibitors
Diuretics
Hospitalization
Outpatients
Demography
Morbidity
Mortality
hydroquinone

Keywords

  • African Americans
  • Comorbidity
  • Ethnic groups
  • Evidence-based medicine
  • Guideline adherence
  • Medication adherence
  • Self-care

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Racial differences in clinical treatment and self-care behaviors of adults with chronic heart failure. / Vaughan Dickson, Victoria; Knafl, George J.; Wald, Joyce; Riegel, Barbara.

In: Journal of the American Heart Association, Vol. 4, No. 4, e001561, 2015.

Research output: Contribution to journalArticle

@article{97dbb1a3d40d43f2a8061305a340e02f,
title = "Racial differences in clinical treatment and self-care behaviors of adults with chronic heart failure",
abstract = "Background-In the United States, the highest prevalence of heart failure (HF) is in blacks followed by whites. Compared with whites, blacks have a higher risk of HF-related morbidity and mortality and HF-related hospitalization. Little research has focused on explaining the reasons for these disparities. The purpose of this study was to examine racial differences in demographic and clinical characteristics in blacks and whites with HF and to determine if these characteristics influenced treatment, or together with treatment, influenced self-care behaviors. Methods and Results-This was a secondary analysis of existing data collected from adults (n=272) with chronic HF enrolled from outpatient sites in the northeastern United States and followed for 6 months. After adjusting for sociodemographic and clinical characteristics within reduced (HFrEF) and preserved ejection fraction (HFpEF) groups, there were 2 significant racial differences in clinical treatment. Blacks with HFrEF were prescribed ACE inhibitors and hydralazine and isosorbide dinitrate (H-ISDN) more often than whites. In the HFpEF group, blacks were taking more medications and were prescribed digoxin and a diuretic when symptomatic. Deficits in HF knowledge and decreased medication adherence, objectively measured, were more prominent in blacks. These racial differences were not explained by sociodemographic or clinical characteristics or clinical treatment variables. Premorbid intellect and the quality of support received contributed to clinical treatment and self-care. Conclusion-Although few differences in clinical treatment could be attributed solely to race, knowledge about HF and medication adherence is lower in blacks than whites. Further research is needed to explain these observations, which may be targets for future intervention research.",
keywords = "African Americans, Comorbidity, Ethnic groups, Evidence-based medicine, Guideline adherence, Medication adherence, Self-care",
author = "{Vaughan Dickson}, Victoria and Knafl, {George J.} and Joyce Wald and Barbara Riegel",
year = "2015",
doi = "10.1161/JAHA.114.001561",
language = "English (US)",
volume = "4",
journal = "Journal of the American Heart Association",
issn = "2047-9980",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Racial differences in clinical treatment and self-care behaviors of adults with chronic heart failure

AU - Vaughan Dickson, Victoria

AU - Knafl, George J.

AU - Wald, Joyce

AU - Riegel, Barbara

PY - 2015

Y1 - 2015

N2 - Background-In the United States, the highest prevalence of heart failure (HF) is in blacks followed by whites. Compared with whites, blacks have a higher risk of HF-related morbidity and mortality and HF-related hospitalization. Little research has focused on explaining the reasons for these disparities. The purpose of this study was to examine racial differences in demographic and clinical characteristics in blacks and whites with HF and to determine if these characteristics influenced treatment, or together with treatment, influenced self-care behaviors. Methods and Results-This was a secondary analysis of existing data collected from adults (n=272) with chronic HF enrolled from outpatient sites in the northeastern United States and followed for 6 months. After adjusting for sociodemographic and clinical characteristics within reduced (HFrEF) and preserved ejection fraction (HFpEF) groups, there were 2 significant racial differences in clinical treatment. Blacks with HFrEF were prescribed ACE inhibitors and hydralazine and isosorbide dinitrate (H-ISDN) more often than whites. In the HFpEF group, blacks were taking more medications and were prescribed digoxin and a diuretic when symptomatic. Deficits in HF knowledge and decreased medication adherence, objectively measured, were more prominent in blacks. These racial differences were not explained by sociodemographic or clinical characteristics or clinical treatment variables. Premorbid intellect and the quality of support received contributed to clinical treatment and self-care. Conclusion-Although few differences in clinical treatment could be attributed solely to race, knowledge about HF and medication adherence is lower in blacks than whites. Further research is needed to explain these observations, which may be targets for future intervention research.

AB - Background-In the United States, the highest prevalence of heart failure (HF) is in blacks followed by whites. Compared with whites, blacks have a higher risk of HF-related morbidity and mortality and HF-related hospitalization. Little research has focused on explaining the reasons for these disparities. The purpose of this study was to examine racial differences in demographic and clinical characteristics in blacks and whites with HF and to determine if these characteristics influenced treatment, or together with treatment, influenced self-care behaviors. Methods and Results-This was a secondary analysis of existing data collected from adults (n=272) with chronic HF enrolled from outpatient sites in the northeastern United States and followed for 6 months. After adjusting for sociodemographic and clinical characteristics within reduced (HFrEF) and preserved ejection fraction (HFpEF) groups, there were 2 significant racial differences in clinical treatment. Blacks with HFrEF were prescribed ACE inhibitors and hydralazine and isosorbide dinitrate (H-ISDN) more often than whites. In the HFpEF group, blacks were taking more medications and were prescribed digoxin and a diuretic when symptomatic. Deficits in HF knowledge and decreased medication adherence, objectively measured, were more prominent in blacks. These racial differences were not explained by sociodemographic or clinical characteristics or clinical treatment variables. Premorbid intellect and the quality of support received contributed to clinical treatment and self-care. Conclusion-Although few differences in clinical treatment could be attributed solely to race, knowledge about HF and medication adherence is lower in blacks than whites. Further research is needed to explain these observations, which may be targets for future intervention research.

KW - African Americans

KW - Comorbidity

KW - Ethnic groups

KW - Evidence-based medicine

KW - Guideline adherence

KW - Medication adherence

KW - Self-care

UR - http://www.scopus.com/inward/record.url?scp=85012299179&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012299179&partnerID=8YFLogxK

U2 - 10.1161/JAHA.114.001561

DO - 10.1161/JAHA.114.001561

M3 - Article

C2 - 25870187

AN - SCOPUS:85012299179

VL - 4

JO - Journal of the American Heart Association

JF - Journal of the American Heart Association

SN - 2047-9980

IS - 4

M1 - e001561

ER -